333 related articles for article (PubMed ID: 1316919)
1. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor.
Pinckard RN; Showell HJ; Castillo R; Lear C; Breslow R; McManus LM; Woodard DS; Ludwig JC
J Immunol; 1992 Jun; 148(11):3528-35. PubMed ID: 1316919
[TBL] [Abstract][Full Text] [Related]
2. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).
Shaw JO; Pinckard RN; Ferrigni KS; McManus LM; Hanahan DJ
J Immunol; 1981 Sep; 127(3):1250-5. PubMed ID: 6267133
[TBL] [Abstract][Full Text] [Related]
3. Alkyl-PAF and acyl-PAF human neutrophil priming for enhanced fMLP- and rC5a-induced superoxide anion production.
Pinckard RN; Prihoda TJ
J Leukoc Biol; 1996 Feb; 59(2):219-28. PubMed ID: 8603994
[TBL] [Abstract][Full Text] [Related]
4. Superoxide responses to formyl-methionyl-leucyl-phenylalanine in primed neutrophils. Role of intracellular and extracellular calcium.
Walker BA; Hagenlocker BE; Ward PA
J Immunol; 1991 May; 146(9):3124-31. PubMed ID: 1849943
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine.
Wirthmueller U; De Weck AL; Dahinden CA
J Immunol; 1989 May; 142(9):3213-8. PubMed ID: 2540238
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
[TBL] [Abstract][Full Text] [Related]
7. [The effect of aldehydogenic and acyl structural analogs of platelet activating factor on the formation of superoxide radicals by human blood leukocytes].
Kuznetsova TI; Kulikov VI
Biokhimiia; 1992 Jan; 57(1):16-20. PubMed ID: 1327185
[TBL] [Abstract][Full Text] [Related]
8. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.
Stewart AG; Harris T; De Nichilo M; Lopez AF
Immunology; 1991 Feb; 72(2):206-12. PubMed ID: 1849872
[TBL] [Abstract][Full Text] [Related]
9. Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils.
Stewart AG; Harris T
Immunology; 1993 Jan; 78(1):152-8. PubMed ID: 8382188
[TBL] [Abstract][Full Text] [Related]
10. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
11. Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells.
Bussolino F; Aglietta M; Sanavio F; Stacchini A; Lauri D; Camussi G
J Immunol; 1985 Oct; 135(4):2748-53. PubMed ID: 2411812
[TBL] [Abstract][Full Text] [Related]
12. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.
Breviario F; Bertocchi F; Dejana E; Bussolino F
J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of platelet-activating factor on superoxide anion production in human eosinophils and neutrophils.
Mabuchi K; Sugiura T; Ojima-Uchiyama A; Masuzawa Y; Waku K
Biochem Int; 1992 May; 26(6):1105-13. PubMed ID: 1321621
[TBL] [Abstract][Full Text] [Related]
14. [Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs].
Orlov SM; Kulikov VI; Pol'ner AA; Bergel'son LD
Biokhimiia; 1985 Apr; 50(4):680-5. PubMed ID: 2408682
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
O'Flaherty JT
J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
[TBL] [Abstract][Full Text] [Related]
16. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.
Sisson JH; Prescott SM; McIntyre TM; Zimmerman GA
J Immunol; 1987 Jun; 138(11):3918-26. PubMed ID: 3035016
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell platelet-activating factor primes neutrophil responses: amplification of endothelial activation by neutrophil products.
Vercellotti GM; Moldow CF; Wickham NW; Jacob HS
J Lipid Mediat; 1990; 2 Suppl():S23-30. PubMed ID: 1966817
[TBL] [Abstract][Full Text] [Related]
18. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion.
Worthen GS; Seccombe JF; Clay KL; Guthrie LA; Johnston RB
J Immunol; 1988 May; 140(10):3553-9. PubMed ID: 2834441
[TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary bypass primes polymorphonuclear leukocytes.
Schwartz JD; Shamamian P; Schwartz DS; Grossi EA; Jacobs CE; Steiner F; Minneci PC; Baumann FG; Colvin SB; Galloway AC
J Surg Res; 1998 Mar; 75(2):177-82. PubMed ID: 9655092
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide responses of human neutrophils.
Walker BA; Hagenlocker BE; Douglas VK; Tarapchak SJ; Ward PA
Lab Invest; 1991 Jan; 64(1):105-12. PubMed ID: 1846654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
